News

Paytient Wins 2025 Best in Business Award, Elevating Care Access

Paytient Wins 2025 Best in Business Award, Elevating Care Access

Paytient's Outstanding Recognition in Patient Experience

Paytient, a pioneer in healthcare affordability and payment solutions, has recently achieved a remarkable milestone by receiving the esteemed Modern Healthcare's 2025 Best in Business Award in the Patient Experience and Engagement category.

Impact of the Medicare Prescription Payment Plan

This accolade not only highlights Paytient's swift deployment of the Medicare Prescription Payment Plan (M3P) but also signals a significant transformation in the healthcare landscape. By supporting nearly half the market, Paytient has established itself as a crucial infrastructure partner for insurers and employers aiming to enhance accessibility in healthcare.

Unprecedented Adoption in 2025

The year 2025 marked a transformative period for Paytient's platform, especially as healthcare costs escalated and patients sought greater control over their choices. With an increasing number of organizations integrating this innovative infrastructure, employees are empowered to manage their healthcare benefits more effectively.

Expanding Access Across Healthcare Providers

In 2025, members accessed services at over 30,000 different healthcare merchants using Paytient, showcasing the demand for flexibility. This impressive reach signifies that employees appreciate having the freedom to select care from preferred providers instead of limiting themselves to restricted networks.

The Significance of Affordability in Healthcare

In the words of Brian Whorley, Founder and CEO of Paytient, "This award acknowledges that affordability is the critical missing link in modern benefit design." He emphasizes that policies and coverage are only effective when individuals can afford them. The recognition underscores Paytient's vital partnership with progressive employers and insurers committed to enhancing financial access for all members.

Transforming Care Payments for Employers

Paytient addresses the challenges faced by self-funded employers and commercial health plans by creating solutions that bridge the gap between escalating costs and the health of the workforce. Traditional healthcare options often fail to offer tangible care, leading to many individuals forgoing necessary services due to financial concerns.

The New Currency of Care

By integrating a flexible payment system into health plans, Paytient revolutionizes the concept of "currency of care." This innovative approach enables employers to move away from a rigid framework, offering a customizable experience that empowers employees to manage how they pay for healthcare.

Demonstrating Measurable Impact

Paytient's solutions have proven to be effective in several significant ways:

  • Bridging the Access Gap: With 80% of members accessing care they might have otherwise skipped due to financial constraints, Paytient is making a real difference.
  • Enhancing Workforce Stability: A notable 94% of members reported reduced financial stress, contributing to a 23% lower turnover rate among users compared to non-users.
  • Better Health Outcomes: 78% of users expressed that their overall health improved due to the Paytient program.

About Paytient

Paytient stands as a leader in healthcare affordability and innovative payment solutions. The company empowers individuals to access medical care when needed, allowing them the flexibility to pay over time free of interest or fees. Over 6,000 employers and insurers are currently using Paytient, putting more than $2 billion in healthcare purchasing power directly into people's hands, ultimately closing the gap between coverage and costs.

Frequently Asked Questions

What award did Paytient receive?

Paytient was awarded Modern Healthcare's 2025 Best in Business Award for its impactful contributions in Patient Experience and Engagement.

How does Paytient benefit employers?

By providing flexible payment solutions, Paytient helps employers manage rising healthcare costs while ensuring employees can access necessary care when they need it.

What is the Medicare Prescription Payment Plan (M3P)?

The M3P allows Medicare beneficiaries better access to their medications and related services, facilitating cost-effective payment options.

How many healthcare merchants use Paytient?

As of 2025, Paytient services are utilized at over 30,000 unique healthcare merchants, demonstrating a widespread acceptance across the industry.

What impacts have Paytient solutions achieved?

Key impacts include increased access to care, reduced financial stress among users, and improved health outcomes, establishing Paytient as a vital resource in healthcare affordability.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 185

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 10

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading
Millrose Faces Securities Fraud Suit Amidst Decline

Updated Category News Views 148

Dark Clouds Over Millrose Properties Holy smokes, folks, if Millrose Properties thought it could skirt under the radar, they were dead wrong. The curtain's been peeled back, and what do we see? A mess of securities fraud allegations and financial hiccups that’s driving its shareholders mad. October wasn’t too friendly—Hunterbrook Media dropped a bombshell revealing...

Continue Reading
Tony Perkins' Church Tour amid Controversial Vote

Updated Category News Views 89

Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...

Continue Reading
Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Updated Category News Views 45

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 77

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
Civista Welcomes Healthcare Leader to Boost Growth

Updated Category News Views 145

Expanding the Boardroom with Healthcare Expertise In an unexpected twist for Civista Bancshares (NASDAQ: CIVB), the financial holding company is roping in some healthcare brass to its board. Jeremy Normington-Slay just snagged a seat at Civista's table, and he's bringing his tough-sledding healthcare leadership chops straight from Firelands Health. A $4.3 billion outfit...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 58

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Quest Diagnostics Faces Class Action After Data Breach

Updated Category News Views 4

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 115

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading

Top 5 Most Recently Viewed Articles

IO Biotech Secures Substantial Debt Financing to Advance Cancer Vaccines

Updated Category News Views 218

Introduction to IO Biotech's Recent Financing IO Biotech, a prominent clinical-stage biopharmaceutical firm, has recently taken a significant step towards enhancing its financial capacity. This move comes in the form of a loan of up to €57.5 million from the European Investment Bank (EIB), an institution dedicated to boosting sustainable ventures within the European...

Continue Reading
Gold Prices Surge: Mining Companies Expand Potential with Rising Markets

Updated Category News Views 247

Gold Prices Remain Elevated As gold prices stabilize above $4,100 per ounce, the mining industry is experiencing unprecedented profit margins. Recent trends in the market indicate significant growth, with a notable increase in activity among exploration and development companies. Buyers and investors alike are capitalizing on the bullish climate within the precious metals...

Continue Reading
Esperion's Strong Q2 2025 Results Highlight Growth Strategy

Updated Category News Views 148

Esperion Celebrates Impressive Growth in Q2 2025 Esperion (NASDAQ: ESPR) recently reported significant financial results for the second quarter ended June 30, 2025, demonstrating a robust year-over-year performance and a commitment to advancing its cardiovascular therapies. Total revenue reached $82.4 million, reflecting a 12% growth as compared to the same period in...

Continue Reading
Understanding the Shift in AMD Options Trading Dynamics

Updated Category News Views 196

What’s Happening with AMD Options Trading? Advanced Micro Devices (NASDAQ: AMD) continues to draw significant attention from high-value investors who appear to be optimistic about the company's future. Recent trades suggest that these investors are adopting a bullish stance, a clear signal for retail traders to take notice. Interpreting Unusual Options Activity...

Continue Reading
Growing Demand for Ternary Cathode NCM Materials in EVs

Updated Category News Views 105

Understanding the Ternary Cathode NCM Material Market The global Ternary Cathode NCM Material market is experiencing significant growth due to a surge in demand for electric vehicle (EV) batteries. Initially valued at approximately USD 9.156 billion, this market is projected to reach an impressive USD 28.65 billion by 2031, reflecting a robust compound annual growth rate...

Continue Reading